Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin Pharmacology in Human Cancers

NCT03477162 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03477162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin Pharmacology in Human Cancers
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Phase 1
Overall status
Terminated
Start date
May 15, 2018
Completion date
November 30, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thoracic neoplasm